{"entity":{"type":"insider","cik":"0001704268","url":"/insider/0001704268","json_url":"/insider/0001704268.json","name":"Mubadala Investment Co PJSC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":34,"n_filings":24,"first":"2017-08-04","last":"2025-09-11","span_basis":"filed_date"},"name_variants":[{"name":"Mubadala Investment Co PJSC","source":"filing","n_filings":24,"first_seen":"2017-08-04","last_seen":"2025-09-11"}],"transactions":[{"id":4947654,"accession":"0000950170-25-101063","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-101063","line_url":"/filing/0000950170-25-101063#line-1","is_derivative":false,"issuer_cik":"0001419351","issuer_name":"MidCap Apollo Institutional Private Lending","issuer_ticker":"NONE","issuer_name_source":null,"issuer_url":"/issuer/0001419351","owner_cik":null,"owner_name":"MIC Capital Management 85 RSC Ltd; Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSC","owner_display_name":"MIC Capital Management 85 RSC Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common shares of beneficial interest","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":773328.0,"shares_display":"773,328","price_per_share":24.16,"price_display":"24.16","price_state":"stated","total_value":18683604.48,"total_display":"18,683,604.48","total_whole":"18,683,604","shares_owned_after":14561742.0,"shares_owned_after_display":"14,561,742","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-07-29","filed_date":"2025-07-31","scope":"insider"},{"id":4793362,"accession":"0000950170-25-114223","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-114223","line_url":"/filing/0000950170-25-114223#line-1","is_derivative":false,"issuer_cik":"0001419351","issuer_name":"MidCap Apollo Institutional Private Lending","issuer_ticker":"NONE","issuer_name_source":null,"issuer_url":"/issuer/0001419351","owner_cik":null,"owner_name":"MIC Capital Management 85 RSC Ltd; Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSC","owner_display_name":"MIC Capital Management 85 RSC Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Shares of Beneficial Interest","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1667108.0,"shares_display":"1,667,108","price_per_share":25.95,"price_display":"25.95","price_state":"stated","total_value":43261452.6,"total_display":"43,261,452.60","total_whole":"43,261,453","shares_owned_after":13788414.0,"shares_owned_after_display":"13,788,414","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-06-14","filed_date":"2025-09-11","scope":"insider"},{"id":8090161,"accession":"0001839882-23-005947","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001839882-23-005947","line_url":"/filing/0001839882-23-005947#line-1","is_derivative":false,"issuer_cik":"0001419351","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001419351","owner_cik":null,"owner_name":"Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSC","owner_display_name":"Mamoura Diversified Global Holding PJSC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":66822.0,"shares_display":"66,822","price_per_share":7.8171,"price_display":"7.82","price_state":"stated","total_value":522354.2562,"total_display":"522,354.26","total_whole":"522,354","shares_owned_after":12985927.0,"shares_owned_after_display":"12,985,927","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-02","filed_date":"2023-03-03","scope":"insider"},{"id":8303962,"accession":"0001387131-23-002722","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-23-002722","line_url":"/filing/0001387131-23-002722#line-1","is_derivative":false,"issuer_cik":"0001419351","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001419351","owner_cik":null,"owner_name":"Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSC","owner_display_name":"Mamoura Diversified Global Holding PJSC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":48867.0,"shares_display":"48,867","price_per_share":7.9416,"price_display":"7.94","price_state":"stated","total_value":388082.1672,"total_display":"388,082.17","total_whole":"388,082","shares_owned_after":12919105.0,"shares_owned_after_display":"12,919,105","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-01","filed_date":"2023-03-02","scope":"insider"},{"id":8343887,"accession":"0001387131-23-002678","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-23-002678","line_url":"/filing/0001387131-23-002678#line-1","is_derivative":false,"issuer_cik":"0001419351","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001419351","owner_cik":null,"owner_name":"Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSC","owner_display_name":"Mamoura Diversified Global Holding PJSC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":815.0,"shares_display":"815","price_per_share":7.97,"price_display":"7.97","price_state":"stated","total_value":6495.55,"total_display":"6,495.55","total_whole":"6,496","shares_owned_after":12870238.0,"shares_owned_after_display":"12,870,238","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-02-28","filed_date":"2023-03-01","scope":"insider"},{"id":8343881,"accession":"0001387131-23-002560","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-23-002560","line_url":"/filing/0001387131-23-002560#line-1","is_derivative":false,"issuer_cik":"0001419351","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001419351","owner_cik":null,"owner_name":"Mubadala Investment Co PJSC; Mamoura Diversified Global Holding PJSC","owner_display_name":"Mubadala Investment Co PJSC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":52500.0,"shares_display":"52,500","price_per_share":7.69,"price_display":"7.69","price_state":"stated","total_value":403725.0,"total_display":"403,725.00","total_whole":"403,725","shares_owned_after":12869423.0,"shares_owned_after_display":"12,869,423","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-02-27","filed_date":"2023-02-28","scope":"insider"},{"id":7953718,"accession":"0001839882-23-004972","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001839882-23-004972","line_url":"/filing/0001839882-23-004972#line-1","is_derivative":false,"issuer_cik":"0001419351","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001419351","owner_cik":null,"owner_name":"Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSC","owner_display_name":"Mamoura Diversified Global Holding PJSC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":109118.0,"shares_display":"109,118","price_per_share":7.639,"price_display":"7.64","price_state":"stated","total_value":833552.402,"total_display":"833,552.40","total_whole":"833,552","shares_owned_after":12816923.0,"shares_owned_after_display":"12,816,923","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-02-24","filed_date":"2023-02-27","scope":"insider"},{"id":8732109,"accession":"0001387131-23-002375","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-23-002375","line_url":"/filing/0001387131-23-002375#line-1","is_derivative":false,"issuer_cik":"0001419351","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001419351","owner_cik":null,"owner_name":"Mubadala Investment Co PJSC; Mamoura Diversified Global Holding PJSC","owner_display_name":"Mubadala Investment Co PJSC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":51864.0,"shares_display":"51,864","price_per_share":7.7856,"price_display":"7.79","price_state":"stated","total_value":403792.3584,"total_display":"403,792.36","total_whole":"403,792","shares_owned_after":12707805.0,"shares_owned_after_display":"12,707,805","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-02-23","filed_date":"2023-02-24","scope":"insider"},{"id":8303958,"accession":"0001387131-23-002324","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-23-002324","line_url":"/filing/0001387131-23-002324#line-1","is_derivative":false,"issuer_cik":"0001419351","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001419351","owner_cik":null,"owner_name":"Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSC","owner_display_name":"Mamoura Diversified Global Holding PJSC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50941.0,"shares_display":"50,941","price_per_share":7.8329,"price_display":"7.83","price_state":"stated","total_value":399015.7589,"total_display":"399,015.76","total_whole":"399,016","shares_owned_after":12655941.0,"shares_owned_after_display":"12,655,941","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-02-22","filed_date":"2023-02-23","scope":"insider"},{"id":8343876,"accession":"0001387131-23-002285","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-23-002285","line_url":"/filing/0001387131-23-002285#line-1","is_derivative":false,"issuer_cik":"0001419351","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001419351","owner_cik":null,"owner_name":"Mubadala Investment Co PJSC; Mamoura Diversified Global Holding PJSC","owner_display_name":"Mubadala Investment Co PJSC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":94418.0,"shares_display":"94,418","price_per_share":7.7435,"price_display":"7.74","price_state":"stated","total_value":731125.783,"total_display":"731,125.78","total_whole":"731,126","shares_owned_after":12605000.0,"shares_owned_after_display":"12,605,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-02-21","filed_date":"2023-02-22","scope":"insider"},{"id":8027985,"accession":"0001387131-23-002254","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-23-002254","line_url":"/filing/0001387131-23-002254#line-1","is_derivative":false,"issuer_cik":"0001419351","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001419351","owner_cik":null,"owner_name":"Mubadala Investment Co PJSC; Mamoura Diversified Global Holding PJSC","owner_display_name":"Mubadala Investment Co PJSC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":63382.0,"shares_display":"63,382","price_per_share":7.7149,"price_display":"7.71","price_state":"stated","total_value":488985.7918,"total_display":"488,985.79","total_whole":"488,986","shares_owned_after":12510582.0,"shares_owned_after_display":"12,510,582","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-02-17","filed_date":"2023-02-21","scope":"insider"},{"id":7825378,"accession":"0001387131-23-002226","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-23-002226","line_url":"/filing/0001387131-23-002226#line-1","is_derivative":false,"issuer_cik":"0001419351","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001419351","owner_cik":null,"owner_name":"Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSC","owner_display_name":"Mamoura Diversified Global Holding PJSC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":42682.0,"shares_display":"42,682","price_per_share":7.8966,"price_display":"7.90","price_state":"stated","total_value":337042.6812,"total_display":"337,042.68","total_whole":"337,043","shares_owned_after":12447200.0,"shares_owned_after_display":"12,447,200","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-02-16","filed_date":"2023-02-17","scope":"insider"},{"id":8618415,"accession":"0001839882-23-003873","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001839882-23-003873","line_url":"/filing/0001839882-23-003873#line-1","is_derivative":false,"issuer_cik":"0001419351","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001419351","owner_cik":null,"owner_name":"Mubadala Investment Co PJSC; Mamoura Diversified Global Holding PJSC","owner_display_name":"Mubadala Investment Co PJSC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6300.0,"shares_display":"6,300","price_per_share":7.946,"price_display":"7.95","price_state":"stated","total_value":50059.8,"total_display":"50,059.80","total_whole":"50,060","shares_owned_after":12404518.0,"shares_owned_after_display":"12,404,518","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-02-14","filed_date":"2023-02-15","scope":"insider"},{"id":7937308,"accession":"0001839882-23-003743","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001839882-23-003743","line_url":"/filing/0001839882-23-003743#line-1","is_derivative":false,"issuer_cik":"0001419351","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001419351","owner_cik":null,"owner_name":"Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSC","owner_display_name":"Mamoura Diversified Global Holding PJSC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":32474.0,"shares_display":"32,474","price_per_share":7.9706,"price_display":"7.97","price_state":"stated","total_value":258837.2644,"total_display":"258,837.26","total_whole":"258,837","shares_owned_after":12398218.0,"shares_owned_after_display":"12,398,218","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-02-13","filed_date":"2023-02-14","scope":"insider"},{"id":8166003,"accession":"0001387131-23-001898","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-23-001898","line_url":"/filing/0001387131-23-001898#line-1","is_derivative":false,"issuer_cik":"0001419351","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001419351","owner_cik":null,"owner_name":"Mubadala Investment Co PJSC; Mamoura Diversified Global Holding PJSC","owner_display_name":"Mubadala Investment Co PJSC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11000.0,"shares_display":"11,000","price_per_share":7.9825,"price_display":"7.98","price_state":"stated","total_value":87807.5,"total_display":"87,807.50","total_whole":"87,808","shares_owned_after":12365744.0,"shares_owned_after_display":"12,365,744","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-02-10","filed_date":"2023-02-13","scope":"insider"},{"id":8212551,"accession":"0001839882-23-002830","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001839882-23-002830","line_url":"/filing/0001839882-23-002830#line-1","is_derivative":false,"issuer_cik":"0001419351","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001419351","owner_cik":null,"owner_name":"Mubadala Investment Co PJSC; Mamoura Diversified Global Holding PJSC","owner_display_name":"Mubadala Investment Co PJSC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":600.0,"shares_display":"600","price_per_share":7.97,"price_display":"7.97","price_state":"stated","total_value":4782.0,"total_display":"4,782.00","total_whole":"4,782","shares_owned_after":12354744.0,"shares_owned_after_display":"12,354,744","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-02-01","filed_date":"2023-02-02","scope":"insider"},{"id":8230779,"accession":"0001387131-23-000851","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-23-000851","line_url":"/filing/0001387131-23-000851#line-1","is_derivative":false,"issuer_cik":"0001419351","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001419351","owner_cik":null,"owner_name":"Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSC","owner_display_name":"Mamoura Diversified Global Holding PJSC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7886.0,"shares_display":"7,886","price_per_share":7.9896,"price_display":"7.99","price_state":"stated","total_value":63005.9856,"total_display":"63,005.99","total_whole":"63,006","shares_owned_after":12354144.0,"shares_owned_after_display":"12,354,144","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-26","filed_date":"2023-01-27","scope":"insider"},{"id":7912031,"accession":"0001839882-23-001552","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001839882-23-001552","line_url":"/filing/0001839882-23-001552#line-1","is_derivative":false,"issuer_cik":"0001419351","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001419351","owner_cik":null,"owner_name":"Mubadala Investment Co PJSC; Mamoura Diversified Global Holding PJSC","owner_display_name":"Mubadala Investment Co PJSC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":24526.0,"shares_display":"24,526","price_per_share":7.8801,"price_display":"7.88","price_state":"stated","total_value":193267.3326,"total_display":"193,267.33","total_whole":"193,267","shares_owned_after":12346258.0,"shares_owned_after_display":"12,346,258","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-25","filed_date":"2023-01-26","scope":"insider"},{"id":8303956,"accession":"0001387131-23-000335","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001387131-23-000335","line_url":"/filing/0001387131-23-000335#line-11","is_derivative":false,"issuer_cik":"0001419351","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001419351","owner_cik":null,"owner_name":"Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSC","owner_display_name":"Mamoura Diversified Global Holding PJSC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":69518.0,"shares_display":"69,518","price_per_share":7.7224,"price_display":"7.72","price_state":"stated","total_value":536845.8032,"total_display":"536,845.80","total_whole":"536,846","shares_owned_after":12321732.0,"shares_owned_after_display":"12,321,732","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-10","filed_date":"2023-01-13","scope":"insider"},{"id":8303952,"accession":"0001387131-23-000335","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001387131-23-000335","line_url":"/filing/0001387131-23-000335#line-10","is_derivative":false,"issuer_cik":"0001419351","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001419351","owner_cik":null,"owner_name":"Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSC","owner_display_name":"Mamoura Diversified Global Holding PJSC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":76046.0,"shares_display":"76,046","price_per_share":7.638,"price_display":"7.64","price_state":"stated","total_value":580839.348,"total_display":"580,839.35","total_whole":"580,839","shares_owned_after":12252214.0,"shares_owned_after_display":"12,252,214","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-09","filed_date":"2023-01-13","scope":"insider"},{"id":8303950,"accession":"0001387131-23-000335","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001387131-23-000335","line_url":"/filing/0001387131-23-000335#line-9","is_derivative":false,"issuer_cik":"0001419351","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001419351","owner_cik":null,"owner_name":"Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSC","owner_display_name":"Mamoura Diversified Global Holding PJSC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":68953.0,"shares_display":"68,953","price_per_share":7.4052,"price_display":"7.41","price_state":"stated","total_value":510610.7556,"total_display":"510,610.76","total_whole":"510,611","shares_owned_after":12176168.0,"shares_owned_after_display":"12,176,168","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-06","filed_date":"2023-01-13","scope":"insider"},{"id":8303948,"accession":"0001387131-23-000335","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001387131-23-000335","line_url":"/filing/0001387131-23-000335#line-8","is_derivative":false,"issuer_cik":"0001419351","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001419351","owner_cik":null,"owner_name":"Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSC","owner_display_name":"Mamoura Diversified Global Holding PJSC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":80035.0,"shares_display":"80,035","price_per_share":7.3787,"price_display":"7.38","price_state":"stated","total_value":590554.2545,"total_display":"590,554.25","total_whole":"590,554","shares_owned_after":12107215.0,"shares_owned_after_display":"12,107,215","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-05","filed_date":"2023-01-13","scope":"insider"},{"id":8303946,"accession":"0001387131-23-000335","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001387131-23-000335","line_url":"/filing/0001387131-23-000335#line-7","is_derivative":false,"issuer_cik":"0001419351","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001419351","owner_cik":null,"owner_name":"Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSC","owner_display_name":"Mamoura Diversified Global Holding PJSC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":91892.0,"shares_display":"91,892","price_per_share":7.8013,"price_display":"7.80","price_state":"stated","total_value":716877.0596,"total_display":"716,877.06","total_whole":"716,877","shares_owned_after":12027180.0,"shares_owned_after_display":"12,027,180","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-04","filed_date":"2023-01-13","scope":"insider"},{"id":8303944,"accession":"0001387131-23-000335","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001387131-23-000335","line_url":"/filing/0001387131-23-000335#line-6","is_derivative":false,"issuer_cik":"0001419351","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001419351","owner_cik":null,"owner_name":"Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSC","owner_display_name":"Mamoura Diversified Global Holding PJSC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":141646.0,"shares_display":"141,646","price_per_share":7.5047,"price_display":"7.50","price_state":"stated","total_value":1063010.7362,"total_display":"1,063,010.74","total_whole":"1,063,011","shares_owned_after":11935288.0,"shares_owned_after_display":"11,935,288","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-01-03","filed_date":"2023-01-13","scope":"insider"},{"id":8303942,"accession":"0001387131-23-000335","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001387131-23-000335","line_url":"/filing/0001387131-23-000335#line-5","is_derivative":false,"issuer_cik":"0001419351","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001419351","owner_cik":null,"owner_name":"Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSC","owner_display_name":"Mamoura Diversified Global Holding PJSC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":99754.0,"shares_display":"99,754","price_per_share":7.5548,"price_display":"7.55","price_state":"stated","total_value":753621.5192,"total_display":"753,621.52","total_whole":"753,622","shares_owned_after":11793642.0,"shares_owned_after_display":"11,793,642","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-30","filed_date":"2023-01-13","scope":"insider"},{"id":8303940,"accession":"0001387131-23-000335","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001387131-23-000335","line_url":"/filing/0001387131-23-000335#line-4","is_derivative":false,"issuer_cik":"0001419351","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001419351","owner_cik":null,"owner_name":"Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSC","owner_display_name":"Mamoura Diversified Global Holding PJSC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":84622.0,"shares_display":"84,622","price_per_share":7.714,"price_display":"7.71","price_state":"stated","total_value":652774.108,"total_display":"652,774.11","total_whole":"652,774","shares_owned_after":11693888.0,"shares_owned_after_display":"11,693,888","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-29","filed_date":"2023-01-13","scope":"insider"},{"id":8303938,"accession":"0001387131-23-000335","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001387131-23-000335","line_url":"/filing/0001387131-23-000335#line-3","is_derivative":false,"issuer_cik":"0001419351","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001419351","owner_cik":null,"owner_name":"Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSC","owner_display_name":"Mamoura Diversified Global Holding PJSC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":71299.0,"shares_display":"71,299","price_per_share":7.1796,"price_display":"7.18","price_state":"stated","total_value":511898.3004,"total_display":"511,898.30","total_whole":"511,898","shares_owned_after":11609266.0,"shares_owned_after_display":"11,609,266","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-28","filed_date":"2023-01-13","scope":"insider"},{"id":8303935,"accession":"0001387131-23-000335","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001387131-23-000335","line_url":"/filing/0001387131-23-000335#line-2","is_derivative":false,"issuer_cik":"0001419351","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001419351","owner_cik":null,"owner_name":"Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSC","owner_display_name":"Mamoura Diversified Global Holding PJSC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":145652.0,"shares_display":"145,652","price_per_share":7.2392,"price_display":"7.24","price_state":"stated","total_value":1054403.9584,"total_display":"1,054,403.96","total_whole":"1,054,404","shares_owned_after":11537967.0,"shares_owned_after_display":"11,537,967","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-27","filed_date":"2023-01-13","scope":"insider"},{"id":8303932,"accession":"0001387131-23-000335","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-23-000335","line_url":"/filing/0001387131-23-000335#line-1","is_derivative":false,"issuer_cik":"0001419351","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001419351","owner_cik":null,"owner_name":"Mamoura Diversified Global Holding PJSC; Mubadala Investment Co PJSC","owner_display_name":"Mamoura Diversified Global Holding PJSC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100378.0,"shares_display":"100,378","price_per_share":7.5158,"price_display":"7.52","price_state":"stated","total_value":754420.9724,"total_display":"754,420.97","total_whole":"754,421","shares_owned_after":11392315.0,"shares_owned_after_display":"11,392,315","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-23","filed_date":"2023-01-13","scope":"insider"},{"id":5483128,"accession":"0001387131-21-004685","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-21-004685","line_url":"/filing/0001387131-21-004685#line-1","is_derivative":false,"issuer_cik":"0001419351","issuer_name":"RECURSION PHARMACEUTICALS, INC.","issuer_ticker":"RXRX","issuer_name_source":null,"issuer_url":"/issuer/0001419351","owner_cik":null,"owner_name":"Mubadala Investment Co PJSC; Mamoura Diversified Global Holding PJSC","owner_display_name":"Mubadala Investment Co PJSC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2777777.0,"shares_display":"2,777,777","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":49999986.0,"total_display":"49,999,986.00","total_whole":"49,999,986","shares_owned_after":2777777.0,"shares_owned_after_display":"2,777,777","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-04-16","filed_date":"2021-04-20","scope":"insider"},{"id":7941690,"accession":"0000947871-19-000080","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-19-000080","line_url":"/filing/0000947871-19-000080#line-1","is_derivative":false,"issuer_cik":"0000002488","issuer_name":"ADVANCED MICRO DEVICES INC","issuer_ticker":"AMD","issuer_name_source":null,"issuer_url":"/issuer/0000002488","owner_cik":"0001704268","owner_name":"Mubadala Investment Co PJSC","owner_display_name":"Mubadala Investment Co PJSC","owner_url":"/insider/0001704268","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34906166.0,"shares_display":"34,906,166","price_per_share":23.43,"price_display":"23.43","price_state":"stated","total_value":817851469.38,"total_display":"817,851,469.38","total_whole":"817,851,469","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-02-05","filed_date":"2019-02-07","scope":"insider"},{"id":8635516,"accession":"0000947871-19-000369","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-19-000369","line_url":"/filing/0000947871-19-000369#line-1","is_derivative":false,"issuer_cik":"0001089872","issuer_name":"GAIA, INC","issuer_ticker":"GAIA","issuer_name_source":null,"issuer_url":"/issuer/0001089872","owner_cik":null,"owner_name":"Mubadala Investment Co PJSC; MDC Capital (Cayman) Ltd","owner_display_name":"Mubadala Investment Co PJSC","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15250.0,"shares_display":"15,250","price_per_share":12.74,"price_display":"12.74","price_state":"stated","total_value":194285.0,"total_display":"194,285.00","total_whole":"194,285","shares_owned_after":1266461.0,"shares_owned_after_display":"1,266,461","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-04","filed_date":"2019-05-14","scope":"insider"},{"id":6515411,"accession":"0000947871-18-000617","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-18-000617","line_url":"/filing/0000947871-18-000617#line-1","is_derivative":false,"issuer_cik":"0000002488","issuer_name":"ADVANCED MICRO DEVICES INC","issuer_ticker":"AMD","issuer_name_source":null,"issuer_url":"/issuer/0000002488","owner_cik":"0001704268","owner_name":"Mubadala Investment Co PJSC","owner_display_name":"Mubadala Investment Co PJSC","owner_url":"/insider/0001704268","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22000000.0,"shares_display":"22,000,000","price_per_share":19.325,"price_display":"19.32","price_state":"stated","total_value":425150000.0,"total_display":"425,150,000.00","total_whole":"425,150,000","shares_owned_after":109906166.0,"shares_owned_after_display":"109,906,166","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-07-30","filed_date":"2018-08-01","scope":"insider"},{"id":9211126,"accession":"0000947871-17-000614","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-17-000614","line_url":"/filing/0000947871-17-000614#line-1","is_derivative":false,"issuer_cik":"0001704268","issuer_name":"ADVANCED MICRO DEVICES INC","issuer_ticker":"AMD","issuer_name_source":null,"issuer_url":"/issuer/0001704268","owner_cik":"0001704268","owner_name":"Mubadala Investment Co PJSC","owner_display_name":"Mubadala Investment Co PJSC","owner_url":"/insider/0001704268","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000000.0,"shares_display":"40,000,000","price_per_share":525600000.0,"price_display":"525,600,000.00","price_state":"stated","total_value":2.1024e+16,"total_display":"21,024,000,000,000,000.00","total_whole":"21,024,000,000,000,000","shares_owned_after":131906166.0,"shares_owned_after_display":"131,906,166","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-08-04","filed_date":"2017-08-04","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":3,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":3},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0002006758","name":"MidCap Apollo Institutional Private Lending","url":"/issuer/0002006758","role":"Ten percent owner","n_filings":2,"first_seen":"2025-07-31","last_seen":"2025-09-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001601830","name":"RECURSION PHARMACEUTICALS, INC.","url":"/issuer/0001601830","role":"Ten percent owner","n_filings":18,"first_seen":"2021-04-20","last_seen":"2023-03-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001089872","name":"GAIA, INC","url":"/issuer/0001089872","role":"Other","n_filings":1,"first_seen":"2019-05-14","last_seen":"2019-05-14"},{"type":"issuer","type_label":"ISSUER","cik":"0000002488","name":"ADVANCED MICRO DEVICES INC","url":"/issuer/0000002488","role":"Director, Ten percent owner","n_filings":3,"first_seen":"2017-08-04","last_seen":"2019-02-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001704268","retrieved_at":"2026-08-24T04:52:56+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}